Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT04354064

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Sponsor: Washington University School of Medicine

View on ClinicalTrials.gov

Summary

Earlier detection of disease recurrence will enable greater treatment options and has strong potential to improve patient outcomes. This project is translational and has the potential to lead to future translational research opportunities, including interventional trials in which therapeutic escalation is offered at the early circulating tumor DNA (ctDNA) molecular residual disease (MRD) detection timepoint. Ultimately, the integration of ctDNA into the clinical workflow has the potential to enhance cancer diagnosis, treatment, surveillance, and prognosis, and guide clinical decision-making in this era of personalized precision medicine.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2019-05-29

Completion Date

2026-12-31

Last Updated

2026-02-20

Healthy Volunteers

Yes

Conditions

Healthy Volunteer Prostate Cancer Head and Neck Cancer Esophageal Cancer Genitourinary Cancer Sarcoma Breast Cancer Colon Cancer Gastrointestinal Cancer Solid Tumor Cancer Lung Cancer Skin Cancer Melanoma

Locations (1)

Washington University School of Medicine

St Louis, Missouri, United States